uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
CYP2C9 genetic variants and losartan oxidation in a Turkish population.
Show others and affiliations
2004 (English)In: Eur J Clin Pharmacol, ISSN 0031-6970, Vol. 60, no 5, 337-42 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2004. Vol. 60, no 5, 337-42 p.
Keyword [en]
Adult, Antihypertensive Agents/adverse effects/*metabolism/urine, Aryl Hydrocarbon Hydroxylases/*genetics/metabolism, Chromatography; High Pressure Liquid, Female, Genetics; Population, Genotype, Humans, Losartan/adverse effects/*metabolism/urine, Male, Middle Aged, Phenotype, Polymorphism; Genetic, Research Support; Non-U.S. Gov't, Turkey
Identifiers
URN: urn:nbn:se:uu:diva-73043PubMedID: 15197523OAI: oai:DiVA.org:uu-73043DiVA: diva2:100954
Available from: 2005-05-31 Created: 2005-05-31 Last updated: 2011-01-12

Open Access in DiVA

No full text

Other links

PubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=15197523&dopt=Citation

Authority records BETA

Dahl, Marja-Liisa

Search in DiVA

By author/editor
Dahl, Marja-Liisa
By organisation
Department of Medical Sciences

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 499 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf